Axel Heidenreich
Researcher Next ID · RN-026379
Researcher · Medicine
Cologne, Austria
- Works count
- 1,470
- Citation count
- 40,185
- H-index
- 92
- i10-index
- 416
Research interests
Publications
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03292
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03296
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.01035
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.06.011
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.01.012
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01480
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy217
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.06.002
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv257
Guidelines on Prostate Cancer
Journal · 2013
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.09.046
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70479-0
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt304
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds579
Focal Therapy in Prostate Cancer—Report from a Consensus Panel
Journal of Endourology · 2010 · https://doi.org/10.1089/end.2009.0596
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
European Urology · 2010 · https://doi.org/10.1016/j.eururo.2010.10.039
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2007.12.025
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2007.12.024
EAU Guidelines on Prostate Cancer
European Urology · 2005 · https://doi.org/10.1016/j.eururo.2005.06.001
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Annals of Oncology · 2004 · https://doi.org/10.1093/annonc/mdh301
Current projects
No projects listed.